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Case–cohort analyses were performed on meat and fish consumption in relation to K-ras mutations in 448 colon and 160 rectal
cancers that occurred during 7.3 years of follow-up, excluding the first 2.3 years, and 2948 subcohort members of The Netherlands
Cohort Study on diet and cancer. Adjusted incidence rate ratios and 95% confidence intervals were computed for colon and rectal
cancer and for K-ras mutation status subgroups. Total fresh meat, most types of fresh meat and fish were not associated with colon or
rectal cancer, neither overall nor with K-ras mutation status. However, several weak associations were observed for tumours with a
wild-type K-ras, including beef and colon tumours, and an inverse association for pork with colon and rectal tumours; for meat
products, an increased association was observed with wild-type K-ras tumours in the colon and possibly with G4A transitions in
rectal tumours.
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Epidemiological evidence on different types of meat, meat
products and fish in relation to colorectal cancer (CRC) risk is
not consistent (Giovannucci and Willett, 1994; Potter, 1996; Norat
et al, 2002) perhaps, in part, due to the heterogeneity of the colon
and rectal cancer end point. Associations may become more
apparent when the molecular events involved in colorectal
carcinogenesis are taken into account.
Most colorectal tumours develop from small adenomatous
polyps through a well-defined sequence of morphological changes
(Hill et al, 1978), associated with the acquisition of somatic
mutations (Vogelstein et al, 1988; Fearon and Vogelstein, 1990). A
genetic alteration that occurs in adenomas (10%) as well as in
carcinomas (40%) of the colorectum is the oncogenic activation of
the K-ras gene by mutations. Activating mutations are mainly
found in codons 12 and 13 (Bos et al, 1987; Vogelstein et al, 1988;
Breivik et al, 1994; Brink et al, 2003); those most frequently
observed are the G4A transitions, G4T and G4C transversions
(Urosevic et al, 1993; Martinez-Garza et al, 1999; Brink et al, 2003).
The link between several types of fresh meat, meat products and
fish, and the pattern of K-ras mutations in CRC is not clear. To
date, only a few case–control and case–case studies have been
conducted on the association between dietary factors and K-ras
mutation status (Bautista et al, 1997; Martinez et al, 1999; Voskuil,
1999; Kampman et al, 2000; O’Brien et al, 2000; Slattery et al,
2000). Four studies reported on different types of meat consump-
tion (Martinez et al, 1999; Kampman et al, 2000; O’Brien et al,
2000; Slattery et al, 2000).
It has been suggested that N-nitroso compounds, present in
processed meat or endogenously formed (Bingham et al, 1996),
may induce G4A transitions at the second base of codon 12 or 13
of the K-ras gene in the human colon (Hughes et al, 2001). High-
temperature cooking of meat proteins generates heterocyclic
aromatic amines (HAA), whereas the process of grilling and
smoking of meat generates polycyclic aromatic hydrocarbons
(PAH) as a result of fat dropping on open flames. HAA-DNA-
adducts can cause transitions and transversions, whereas PAHs
could induce G4T transversions in the K-ras gene. Results from
relevant animal experiments, however, are not consistent (Vineis
and McMichael, 1996).
Since high meat and fish consumption could contribute to
acquired genetic alterations in the K-ras oncogene in colon and
rectal tumours, these dietary items have been studied in relation to
the risk of specific point mutations in the K-ras oncogene in
colorectal cancer patients studied within The Netherlands Cohort
Study on diet and cancer (NLCS).
MATERIALS AND METHODS
Study population
The study subjects are incident colon and rectal cancer cases and
subcohort members from the NLCS, which has been described in
detail elsewhere (Van den Brandt et al, 1990a). Briefly, the cohort
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ystudy was initiated in 1986 and includes 58279 men and 62573
women, aged 55–69 years at baseline, who originated from 204
Dutch municipalities with computerised population registries. A
self-administered questionnaire on diet and other risk factors for
cancer was completed at baseline. The entire cohort is being
monitored for cancer occurrence by annual record linkage to The
Netherlands Cancer Registry (NCR, nine cancer registries in The
Netherlands) and to PALGA, a nationwide network and registry of
histo- and cytopathology (www.palga.nl) (Van den Brandt et al,
1990b). In the municipalities included in the NLCS, the NCR and
PALGA, together, have nearly 100% coverage since the start of the
study (Schouten et al, 1993, 1994; Van der Sanden et al, 1995).
PALGA also provides necessary information on the identification
of the pathology laboratory location of the storage of paraffin-
embedded blocks of the eligible CRC patients. Accumulation of
person-time in the cohort has been estimated through biennial
vital status follow-up of a subcohort of 3500 men and women who
were randomly selected after baseline exposure measurement.
Cases with prevalent cancer other than nonmelanoma skin cancer
were excluded from the subcohort, which left 3346 men
and women for analyses.
The first 2.3 years of follow-up were excluded due to incomplete
coverage of PALGA alone in some of the municipalities included in
the NLCS. Within this period, 83 subcohort members were either
deceased or diagnosed with cancer other than nonmelanoma skin
cancer, leaving 3263 men and women for analysis. From 1989 till
1994, 929 incident cases with histologically confirmed CRC were
observed of whom 819 could also be linked to a PALGA report of
the lesion. The PALGA database was used to identify and locate
tumour tissue in Dutch pathology laboratories. Colorectal cancer
was classified according to site as follows: colon, that is, cecum
through sigmoid colon (ICD-O-1 codes: 153.0, 153.1, 153.2, 153.3,
153.4, 153.5, 153.6, 153.7, 153.8, 153.9), rectosigmoid (ICD-O-1
code 154.0) and rectum (ICD-O-1 code 154.1). Information about
age at baseline, sex and family history of CRC (at baseline) was
retrieved from the NLCS database.
Tissue samples
This study is based on data of gene mutation analysis from CRC
patients, described in detail elsewhere (Brink et al, 2003). Briefly,
tumour material of all CRC patients was collected after approval by
the Medical Ethics Committees of Maastricht University, the NCR
and PALGA. Subsequently, all pathology laboratories in The
Netherlands agreed to make relevant tissue samples available upon
request from PALGA. Tissue samples of the 819 cases were
distributed among 54 pathology laboratories throughout The
Netherlands. Tumour tissue collection started in August 1999 and
was completed in December 2001. The loss to follow-up of tissue
samples of cases amounted to 5%. Tissue samples from nine
patients registered in one pathology laboratory could not be
retrieved due to administrative inconsistencies, leaving 810 tissue
samples for collection. For 34 cases, paraffin-embedded material
was not available in the archives of pathology laboratories, leaving
776 cases for the determination of the K-ras mutation status. For
39 cases (5%), the K-ras mutation status could not be determined,
that is, for 20 cases only normal colonic mucosa was available, 10
cases were revised with an benign adenoma (AdB) instead of an
adenocarcinoma, for six cases the yield of DNA was not sufficient
to determine K-ras mutation status and for three cases the
available tissue did not include malignant CRC tissue. Finally,
tumour material from 737 incident colorectal adenocarcinoma
cases was available of whom 476 were colon cancer cases, 85 were
rectosigmoid cancer cases and 176 were rectal cancer cases.
Statistical analyses were performed separately for colon and rectal
cancer as differences in the aetiology of colon and rectal cancer
have been reported (Potter, 1996). Since the rectosigmoid can be
considered as a clinically applied term rather than an anatomically
defined transitional zone between the colon and rectum, patients
with a rectosigmoid tumour were excluded from data-analyses.
Moreover, the number of patients with a rectosigmoid tumour was
too small for adequate stratified analyses (Brink et al, 2003).
Detection of K-ras mutations
Mutation analysis of the exon 1 fragment of the K-ras oncogene,
spanning codons 8–29, was performed on archival colorectal
adenocarcinoma specimens of all 737 CRC patients using
macrodissection, nested polymerase chain reaction (PCR) and
direct sequencing of purified fragments, which has been described
in detail elsewhere (Brink et al, 2003). The method of mutation
detection was validated by the confirmation of reported K-ras
status in CRC cell lines and a good correlation between fresh-
frozen and routinely fixed, paraffin-embedded tissue. The detec-
tion limit was 5% mutated DNA. Duplicate analyses revealed a
good reproducibility (88%) (Brink et al, 2003). Two observers (GR
and ML) independently performed evaluation of mutation analysis
and data-entry.
The food frequency questionnaire
The dietary section of the questionnaire covered a 150-item
semiquantitative food frequency, which concentrated on habitual
consumption of food and beverages during the year preceding the
start of the study. Daily mean nutrient intakes were calculated
using the computerised Dutch food composition table (Dutch food
composition table (NEVO table, 1986)), by multiplying frequencies
and portion sizes of all food items with their tabulated nutrient
contents. The questionnaire was validated against a 9-day diet
record (Goldbohm et al, 1994a). The Spearman correlation
coefficients for total fresh meat, meat products and fish were
0.46, 0.54 and 0.53, respectively (Goldbohm et al, 1994a).
Questionnaire data were key-entered twice and processed for all
incident cases in the cohort and for all subcohort members in a
manner blinded with respect to case/subcohort status. This was
carried out in order to minimise observer bias in coding and
interpretation of the data.
For 257 subjects (28 incident colon adenocarcinoma cases, 16
incident rectal adenocarcinoma cases and 215 subcohort members;
two subcohort members were also colon or rectal cancer cases),
dietary data were incomplete or inconsistent, and they were
excluded from the analyses. These subjects either (1) left 60 or
more (out of 150) questionnaire items blank and ate fewer than 35
items at least once per month and/or (2) left one or more item
blocks (groups of items, i.e. beverages) blank. Additional details
are given elsewhere (Goldbohm et al, 1994a). Hence, 448 colon and
160 rectal cases and 3048 subcohort members were available for
data-analyses.
The food frequency questionnaire contained 14 items on the
consumption of meat with the main (hot) meal (mainly fresh meat,
including chicken), five items on the consumption of meat
products, which are used as sandwich filling and three items on
fish consumption. For the serving size of total fresh meat, a
question was included on the quantity of meat usually purchased
(per person, per meal). Fresh meat is defined as meat that has not
undergone some form of preservation, that is, smoking, fermenta-
tion and/or treatment with nitrate and/or nitrite salt (‘curing’) and
which includes beef, pork, minced meat, chicken, liver and other
meat (i.e. sausages). Coding of fresh meat items was based on
raw weight to take into account the amount of fat originally
present in the meat but ultimately ending up into the gravy, which
is usually consumed as well. Meat products are defined as
meat items that have undergone some form of preservation
(mostly cured, sometimes also smoked or fermented). For
chicken and fish, standard serving sizes were used. Meat items
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daily consumption in grams.
Quartiles of the consumption of total fresh meat, beef, pork,
liver, minced meat, other meat and meat products were computed
for men and women separately, based on the distribution of
subcohort members as described in detail later. For chicken and
fish, groups were classified into a nonuser and three user
categories (5.3–13.2, 13.2–22.8 and X22.8gday
 1 for chicken
and 0–10, 10–20 and X20gday
 1 for fish) and this classification
was used for both men and women.
Daily intake of dietary fibre (gday
 1), alcohol (gday
 1), fruit
(gday
 1), vegetables (gday
 1) and total energy (kcalday
 1) and
age at baseline (years), sex (men/women), Quetelet Index (QI;
kgm
 2), physical activity (o30minday
 1, 30–60minday
 1,6 0 –
90minday
 1, 490minday
 1), family history of CRC (yes/no) and
smoking status (never/ex/current) were regarded as potential
confounders.
Statistical analysis
The overall frequency of K-ras mutations as well as the type of
mutation were computed for all colon and rectal cancer cases as
described elsewhere (Brink et al, 2003). Mean values of the
continuous variables age at baseline (years), consumption of total
fresh meat, beef, pork, minced meat, chicken, liver, other meat,
meat products, fish, dietary fibre, alcohol, fruit, vegetables, total
energy and QI were evaluated for subcohort members and colon
and rectal cancer cases with wild-type and mutated K-ras gene.
Distributions of the categorical variables sex, family history of
CRC, smoking status and physical activity were evaluated for
subcohort members and colon and rectal cancer patients with
wild-type and mutated K-ras gene and tested for differences
between patient groups with the w
2-test. Differences in mean values
of the continuous variables between patients with wild-type and
mutated K-ras gene were tested with the Student t-test or the
Mann–Whitney U-test if the variables were not normally dis-
tributed. The statistical software package SPSS (version 9) was
used for these analyses.
Incidence rate ratios (RRs) and corresponding 95% confidence
intervals (CI) were estimated for colon and rectal cancer cases with
wild-type or mutated K-ras gene tumours. RRs were computed
using Cox regression models with the STATA statistical software
package (intercooled STATA, version 7) according to consumption
of quartiles or categories and one standard deviation (s.d.) of
increase in fresh meat, meat products and fish, all based on the
distribution in the subcohort. The lowest quartile or category of
consumption was regarded as the reference category. The person-
years at risk, estimated from the subcohort, were used in the
denominator of the incidence rates (Van den Brandt et al, 1990a).
Standard errors were estimated using the robust Huber–White
sandwich estimator to account for additional variance introduced
by sampling from the cohort. This method is equivalent to the
variance–covariance estimator as presented by Barlow et al
(1999). The proportional hazards assumption was tested using
the scaled Schoenfeld residuals (Schoenfeld, 1982). Those variables
that were found to contribute substantially (Po0.10) to the
multivariate model for colon and/or rectal cancer (age, sex,
QI, smoking, energy intake and family history of CRC) were
included as covariates in all multivariate analyses. Interactions
between total fresh meat, meat products and fish consumption on
one hand and sex on the other hand were tested for colon and
rectal cancer separately and not found to be statistically
significant. Therefore, results for men and women are presented
together. Finally, age at baseline, sex, family history of CRC,
smoking status, QI and the intake of energy were confounders
for either one or both of the models, that is, with colon or rectal
cancer cases, and were therefore included as covariates for all
models to be tested. Since 100 subcohort members had missing
values for QI, results in the tables (except for Table 1) concern
2948 subcohort members. For each analysis, linear trends were
evaluated with the Wald test of the regression coefficient estimate
by fitting ordinal exposure variables (quartiles/categories of
consumption) as continuous terms.
RESULTS
The overall frequency and spectrum of mutations in the K-ras gene
have been presented in detail elsewhere (Brink et al, 2003). In brief,
a total of 227 mutations were found in 218 (36%) out of 608 colon
and rectal cancer patients. The most frequently observed muta-
tions are the G4A transitions (54%), G4T transversions (33%)
and G4C transversions (7%). The observed frequencies of the
mutations in this series of patients are similar to the frequencies of
the 737 CRC cases, including the rectosigmoid cancer cases, for
whom K-ras mutation status was determined (Brink et al, 2003).
Table 1 shows the baseline characteristics of the study
population. Colon and rectal cancer cases were more often men,
were older, more frequently reported a family history of CRC, had
a higher daily alcohol intake and were less frequently never
smokers as compared to the subcohort. Colon cancer cases with a
K-ras mutation in their tumour had a lower daily consumption of
meat products, a higher intake of dietary fibres and were
significantly older than colon cancer cases with a wild-type K-ras
tumour (P-values 0.02, 0.02 and 0.006, respectively). There were no
statistically significant differences between colon cancer cases with
and without a K-ras mutation in their tumour in dietary
consumption of total fresh meat, beef, pork, minced meat, liver,
chicken, other meat, fish and other factors presented in Table 1.
Rectal cancer cases with a K-ras mutation in their tumour had a
lower daily consumption of minced meat, a higher daily
consumption of pork and were less frequently men than rectal
cancer cases with a wild-type K-ras gene in their tumour (P-values
0.03, 0.06 and 0.03, respectively). No statistically significant
differences were observed between rectal cancer cases with and
without a K-ras mutation in their tumours for other factors
presented in Table 1.
Associations between the consumption of total fresh meat,
different types of fresh meat, that is, beef, pork, minced meat, liver,
chicken and other meat, meat products and fish, and the risk of
colon or rectal cancer are presented in Table 2. Relative ratios and
95% CI for colon and rectal cancer were presented after adjustment
for age and sex and after adjustment for age, sex, smoking QI,
energy intake and family history of CRC. The age-and-sex adjusted
RR and the multivariate RR were similar. Frequent consumption of
total fresh meat, minced meat, liver, chicken, other meat, meat
products and fish was not significantly associated with the risk of
colon or rectal cancer (Table 2). A high intake of beef was
borderline positively associated with the risk of colon cancer (RR
for highest vs lowest quartile of consumption 1.28, 95% CI 0.96–
1.72; Ptrend 0.06). There was no association between beef and rectal
cancer risk. A high consumption of pork was, however, borderline
inversely associated with the risk of colon cancer (RR for highest
vs lowest quartile of consumption 0.77, 95% CI 0.57–1.04; Ptrend
0.07) and rectal cancer (RR for highest vs lowest quartile of
consumption 0.70, 95% CI 0.43–1.13; Ptrend 0.09).
Associations of total fresh meat, beef, pork, minced meat, liver,
chicken, other meat, and meat products and fish with wild-type or
mutated K-ras gene in colon or rectal tumours are presented in
Table 3. Results will first be presented for tumours with a wild-type
K-ras gene. No clear associations were observed for the highest vs
the lowest consumption of total fresh meat, minced meat, liver,
chicken, other meat and fish and colon and rectal tumours with a
wild-type K-ras gene. A nonsignificant, increased association was
observed between beef and wild-type K-ras colon tumours (RR for
highest vs lowest quartile of consumption 1.36, 95% CI 0.96–1.93;
Meat and K-ras gene in sporadic colorectal cancer
M Brink et al
1312
British Journal of Cancer (2005) 92(7), 1310–1320 & 2005 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yPtrend 0.08). No association was observed for beef and rectal
tumours with a wild-type K-ras gene. On the other hand, a high
consumption of pork was inversely associated with wild-type K-ras
colon and rectal tumours (RR for highest vs lowest quartile of
consumption 0.72, 95% CI 0.51–1.02; Ptrend 0.05 and 0.50, 95% CI
0.26–0.93; Ptrend 0.01, respectively). A high consumption of meat
products showed a significant increased association with colon
tumours with a wild-type K-ras gene (RR for highest vs lowest
quartile of intake 1.42, 95% CI 1.00–2.03; Ptrend 0.03). No clear
association was found for high consumption of meat products and
rectal tumours with a wild-type K-ras gene. Regarding colon and
rectal tumours that harbour a K-ras mutation, no clear associations
were observed between highest vs lowest quartile of consumption
of different types of fresh meat, meat products and fish.
Subgroup analyses were performed to evaluate the associations
between total fresh meat, different types of fresh meat, meat
products and fish, and specific types of K-ras point mutations
(G4A transitions and G4To rG 4C transversions) in colon and
rectal tumours (Table 4). Results will first be presented for
tumours with a G4A transition in the K-ras gene. Total fresh meat
consumption was not associated with G4A transitions in the
colon tumours, but an inverse association with G4A transitions in
the rectal tumours was observed. However, none of the specific
types of fresh meat, that is, beef, pork, minced meat, liver, chicken,
other meat, nor fish were associated with the risk of G4A
transitions in both colon and rectal tumours. For meat products, a
borderline significant trend with increased risk of rectal tumours
harbouring G4A transitions was observed (RR for highest vs
lowest quartile of intake 2.37, 95% CI 0.75–7.51; Ptrend 0.07).
Regarding G4To rG 4C transversions in colon and rectal
tumours, no clear associations were observed for total fresh meat,
the different types of fresh meat, meat products and fish.
DISCUSSION
In this large cohort study with 448 incident colon and 160 incident
rectal cancer patients, no associations were observed between total
fresh meat and fish, and the risk of colon or rectal cancer, either
overall or after K-ras mutation status was taken into account. This
was also observed for specific types of fresh meat. However, several
weak associations were observed regarding tumours harbouring a
wild-type K-ras gene. An increased association for high consump-
tion of beef and an inverse association for high consumption of
pork, and the risk of colon tumours were observed. In addition,
consumption of pork was inversely associated with rectal tumours
with a wild-type K-ras gene. For meat products, an increased
association was observed with wild-type K-ras tumours in the
colon and a nonsignificant positive association with G4A
transitions in the K-ras gene in rectal tumours.
Earlier results on meat and CRC in the NLCS, based on 3.3 years
of follow-up, showed no association for high consumption of total
fresh meat and fish and colon cancer risk in men and women. A
positive association for both men and women was observed for
Table 1 Meat variables and other characteristics (mean7s.d.) of the study population at baseline
Colon cancer Rectal cancer
Subcohort Wild-type K-ras
  Mutated K-ras
+b P-value
a Wild-type K-ras
  Mutated K-ras
+c P-value
a
N 3048 297 151 93 67
Sex (% men) 48.4 51.5 58.9 0.14 72.0 55.2 0.03
Age (years) 61.474.2 62.774.0 63.874.1 0.006 62.674.1 62.274.0 0.50
Meat variables
Total fresh meat (gday
 1) 99.7742.2 98.4737.0 99.3739.1 0.82 100.6740.3 95.7736.6 0.43
Beef (gday
 1) 25.7722.5 27.9721.8 27.6723.6 0.90 27.6724.6 22.5723.3 0.19
Pork (gday
 1) 38.4730.3 36.3730.1 37.6729.6 0.67 32.2727.0 40.8729.3 0.06
Minced meat (gday
 1) 18.3717.3 17.2713.4 18.0716.0 0.57 23.2725.2 16.7712.4 0.03
Liver (gday
 1) 2.074.4 1.974.2 1.874.1 0.29 2.174.1 1.974.4 0.90
Chicken (gday
 1) 13.7715.6 13.2715.5 12.4715.2 0.55 14.5715.6 12.3712.8 0.62
Other meat (gday
 1) 2.576.4 2.978.0 2.775.9 0.95 2.274.1 2.774.8 0.84
Meat products (gday
 1) 13.2715.0 15.0716.6 11.7713.2 0.02 13.5714.7 15.0712.9 0.51
Fish and shellfish (gday
 1) 12.7715.0 11.4713.5 13.2715.7 0.24 12.4713.1 11.0710.3 0.71
Other dietary factors
Fibre (gday
 1) 27.078.2 26.777.6 27.778.8 0.02 27.878.0 27.677.8 0.87
Alcohol (gday
 1) 10.1714.1 11.0715.4 10.8714.2 0.59 13.8717.6 11.2712.2 0.30
Fruit (gday
 1) 176.37117.7 172.77123.7 176.97122.2 0.73 184.37145.8 180.77129.9 0.87
Vegetable (gday
 1) 193.6782.3 183.3778.2 198.0787.0 0.07 192.9772.4 188.07110.6 0.74
Energy (kcalday
 1) 1919.47518.1 1916.57494.4 1902.77472.9 0.78 2027.37517.4 1997.07449.1 0.70
Other characteristics
Quetlet Index (kgm
 2) 25.173.1 25.573.2 25.873.3 0.42 24.972.8 25.572.9 0.20
Family history of CRC (% yes) 5.6 13.5 9.3 0.20 9.7 11.9 0.66
Smoker (%)
Never 37.0 36.7 37.1 25.8 34.3
Ex smoker 35.2 43.1 46.4 41.9 43.3
Current smoker 27.8 20.2 16.6 0.62 32.3 22.4 0.31
Physical activity (%)
d
o30minday
 1 20.9 19.7 20.3 18.5 22.7
30–60minday
 1 32.7 33.7 32.4 27.2 27.3
60–90minday
 1 30.9 29.6 29.1 32.6 34.8
490minday
 1 15.5 17.0 18.2 0.98 21.7 15.2 0.73
aComparing cases with at least one K-ras mutation to cases without a K-ras mutation.
bSix out of 151 colon cancer cases had more than one K-ras mutation.
cThree out of 67
rectal cancer cases had more than one K-ras mutation.
dFor 41 subcohort members and nine colorectal cancer cases, information on physical activity was not available.
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intake of total fresh meat, meat products and fish
Quartile/category of intake
Exposure 1
a 234 P for trend
RR (95% CI) for one
s.d. increase in intake
b
Total fresh meat
Median intake (gday
 1) Men 61 91 110.7 150.8
Women 50.7 80.3 103.4 139.2
Cases Colon 109 112 123 104
Rectum 40 48 40 32
Person-years 3661 3701 3660 3715
RR (95% CI)
c Colon 1 1.03 (0.77–1.37) 1.16 (0.88–1.54) 0.99 (0.74–1.33) 0.8 0.97 (0.89–1.07)
Rectum 1 1.21 (0.78–1.86) 1.03 (0.65–1.61) 0.82 (0.51–1.33) 0.33 0.94 (0.80–1.09)
RR (95% CI)
d Colon 1 1.05 (0.78–1.41) 1.12 (0.83–1.49) 0.96 (0.70–1.31) 0.92 0.96 (0.87–1.06)
Rectum 1 1.11 (0.71–1.73) 0.93 (0.59–1.47) 0.72 (0.44–1.19) 0.14 0.89 (0.76–1.05)
Beef
Median intake (gday
 1) Men 4.1 16.1 30 51.4
Women 3 14 25.5 46.9
Cases Colon 100 98 108 142
Rectum 39 49 32 40
Person-years 3648 3742 3507 3840
RR (95% CI)
c Colon 1 0.94 (0.70–1.27) 1.08 (0.80–1.44) 1.23 (0.93–1.63) 0.09 1.05 (0.96–1.15)
Rectum 1 1.22 (0.79–1.88) 0.84 (0.52–1.37) 0.90 (0.57–1.43) 0.35 0.95 (0.79–1.13)
RR (95% CI)
d Colon 1 0.98 (0.72–1.33) 1.09 (0.81–1.48) 1.28 (0.96–1.72) 0.06 1.06 (0.97–1.17)
Rectum 1 1.25 (0.80–1.96) 0.82 (0.49–1.36) 0.92 (0.57–1.49) 0.38 0.94 (0.78–1.14)
Pork
Median intake (gday
 1) Men 7.9 28 44.3 76
Women 5 22.5 40.1 66.2
Cases Colon 121 120 109 98
Rectum 44 46 36 34
Person-years 3659 3658 3688 3733
RR (95% CI)
c Colon 1 1.03 (0.78–1.35) 0.94 (0.71–1.24) 0.86 (0.76–1.37) 0.24 0.96 (0.87–1.07)
Rectum 1 1.07 (0.70–1.64) 0.84 (0.53–1.33) 0.80 (0.50–1.28) 0.22 0.90 (0.76–1.07)
RR (95% CI)
d Colon 1 0.98 (0.74–1.30) 0.90 (0.67–1.20) 0.77 (0.57–1.04) 0.07 0.93 (0.83–1.04)
Rectum 1 1.01 (0.66–1.56) 0.81 (0.51–1.28) 0.70 (0.43–1.13) 0.09 0.87 (0.72–1.03)
Minced meat
Median intake (gday
 1) Men 3.2 11.5 21 37.8
Women 0 9.6 18.1 32.9
Cases Colon 104 119 128 97
Rectum 33 38 54 35
Person-years 3648 3718 3692 3679
RR (95% CI)
c Colon 1 1.12 (0.84–1.49) 1.28 (0.97–1.70) 0.95 (0.70–1.28) 0.99 0.95 (0.86–1.04)
Rectum 1 1.13 (0.70–1.82) 1.67 (1.07–2.61) 1.07 (0.66–1.74) 0.38 1.09 (0.94–1.26)
RR (95% CI)
d Colon 1 1.11 (0.83–1.50) 1.26 (0.94–1.69) 0.93 (0.68–1.27) 0.88 0.95 (0.85–1.05)
Rectum 1 1.06 (0.66–1.73) 1.60 (1.01–2.52) 1.01 (0.62–1.67) 0.5 1.08 (0.92–1.27)
Liver
Median intake (gday
 1) Men 0 4.1
Women 0 3.7
Cases Colon 295 153
Rectum 99 61
Person-years 9589 5148
RR (95% CI)
c Colon 1 1.02 (0.83–1.26) 0.84 1.00 (0.91–1.11)
Rectum 1 1.16 (0.83–1.62) 0.38 1.02 (0.88–1.18)
RR (95% CI)
d Colon 1 1.04 (0.84–1.29) 0.71 1.02 (0.92–1.12)
Rectum 1 1.11 (0.79–1.57) 0.54 1.02 (0.88–1.18)
Chicken
Median intake (gday
 1) Men/women 0 5.3 13.2 22.8
Cases Colon 125 101 98 124
Rectum 35 44 33 48
Person-years 3457 3564 3616 4100
RR (95% CI)
c Colon 1 0.81 (0.61–1.07) 0.78 (0.58–1.04) 0.86 (0.66–1.13) 0.3 0.96 (0.86–1.07)
Rectum 1 1.26 (0.80–2.00) 0.92 (0.56–1.50) 1.18 (0.76–1.86) 0.77 1.00 (0.86–1.16)
RR (95% CI)
d Colon 1 0.85 (0.63–1.14) 0.81 (0.60–1.08) 0.87 (0.66–1.15) 0.34 0.95 (0.85–1.07)
Rectum 1 1.26 (0.79–2.03) 0.94 (0.57–1.55) 1.12 (0.70–1.79) 0.96 0.98 (0.83–1.14)
Other meat
Median intake (gday
 1) Men 0 6.6
Women 0 7
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ymeat products, which consist mainly of cured meat (Goldbohm
et al, 1994b). Rectal cancer was not included in these analyses.
These findings were in line with the findings of a meta-analysis
conducted by Norat et al (2002). In total, 29 studies were evaluated,
including 22 case–control and seven cohort studies for investigat-
ing the association between processed meat and CRC. A high
consumption of processed meat was found to be associated with a
moderate, but significant, increase in CRC risk. In the current
study, after 7.3 years of follow-up and with the exclusion of the
first 2.3 years, these findings were similar to the earlier results
on meat and CRC in the NLCS, that is, neither an association
was observed for total fresh meat, different types of fresh meat,
nor for fish. However, in the current study, no significant
association was observed between meat products and colon or
rectal cancer risk overall.
With regard to K-ras mutations, two case–control studies with
colon cancer patients, one with 2418 patients and 2410 controls
(Slattery et al, 2000), the other with 185 patients (Voskuil, 1999;
Kampman et al, 2000), and one cross-sectional case–case study
with rectal cancer patients (O’Brien et al, 2000) have previously
been conducted and have reported on the association between
meat consumption and K-ras mutations. In none of these studies
an association between meat consumption and colon or rectal
cancer was observed after the K-ras gene mutation status was taken
into account. The current cohort study on total fresh meat,
different types of fresh meat, meat products and fish and specific
K-ras mutations is, to our knowledge, the only prospective study
performed to date. The prospective design of this study and the
high completeness of follow-up of cancer incidence and of the
subcohort make information and selection bias unlikely. In
addition, as a result of the exclusion of the first 2.3 years of
follow-up, the chance of information bias due to potential
preclinical colorectal cancer is minimal.
Epidemiological studies have indicated that consumption of
broiled, fried, barbequed or smoked meats may increase the risk of
CRC (Gerhardsson de Verdier et al, 1991; Augustsson et al, 1999;
Kampman et al, 1999), although these findings were not consistent.
Augustsson et al (1999) observed an inverse association between
high intake of HAA and the risk of colon and rectal cancer.
However, Gerhardsson de Verdier et al (1991) observed an
increased association for total meat intake as well as frequent
consumption of brown gravy and a preference for a heavily
browned meat surface and the risk of CRC. The relative risks (RR)
were higher for rectal than for colon cancer. High-temperature
cooking of meat proteins generates HAA, whereas the process of
grilling and smoking of meat forms PAH as a result of fat dropping
on open flames. Animal and in vitro studies have shown that HAA-
DNA-adducts can cause transitions and transversions, as observed
in the K-ras oncogene. However, results from animal experiments
are not entirely consistent (Vineis and McMichael, 1996). In
humans, a higher prevalence of G4T transversions in the K-ras
gene was observed in 37 colorectal tumours from Yugoslavia,
which the authors explain as possibly being due to the extensive
use of barbequed and smoked meat throughout the year in
Yugoslavia (Urosevic et al, 1993). Unfortunately, information on
meat preparation, including cooking methods, was not collected at
baseline in the current study. Since fresh meat generally needs
further preparation, this type of meat may be an important source
of these carcinogens. Hence, it is plausible that associations
between fresh meat and colon or rectal cancer with specific point
Table 2 (Continued)
Quartile/category of intake
Exposure 1
a 234 P for trend
RR (95% CI) for one
s.d. increase in intake
b
Cases Colon 313 135
Rectum 105 55
Person-years 10421 4316
RR (95% CI)
c Colon 1 1.13 (0.91–1.41) 0.25 1.05 (0.96–1.15)
Rectum 1 1.29 (0.91–1.81) 0.15 0.98 (0.86–1.11)
RR (95% CI)
d Colon 1 1.16 (0.92–1.46) 0.2 1.08 (0.98–1.18)
Rectum 1 1.34 (0.95–1.91) 0.1 1.00 (0.88–1.15)
Meat products
e
Median intake (gday
 1) Men 1 7.4 15.8 33.3
Women 0 4.3 10.5 22.4
Cases Colon 113 94 118 123
Rectum 44 30 39 47
Person-years 3588 3624 3794 3732
RR (95% CI)
c Colon 1 0.87 (0.65–1.17) 1.06 (0.80–1.40) 1.13 (0.86–1.49) 0.22 1.04 (0.95–1.14)
Rectum 1 0.70 (0.43–1.12) 0.88 (0.57–1.38) 1.09 (0.71–1.66) 0.54 1.01 (0.89–1.16)
RR (95% CI)
d Colon 1 0.89 (0.65–1.21) 1.06 (0.78–1.42) 1.17 (0.86–1.59) 0.19 1.05 (0.94–1.16)
Rectum 1 0.68 (0.41–1.11) 0.84 (0.53–1.35) 1.04 (0.64–1.68) 0.7 0.97 (0.84–1.13)
Fish
Median intake (gday
 1) Men 0 4.6 14.8 30.5
Women 0 4.6 15.5 28.2
Cases Colon 123 122 116 87
Rectum 48 33 48 31
Person-years 4235 3238 4444 2820
RR (95% CI)
c Colon 1 1.31 (1.00–1.73) 0.92 (0.70–1.21) 1.05 (0.78–1.41) 0.64 0.94 (0.85–1.04)
Rectum 1 0.86 (0.54–1.36) 0.93 (0.62–1.41) 0.89 (0.56–1.42) 0.7 0.91 (0.79–1.06)
RR (95% CI)
d Colon 1 1.30 (0.97–1.73) 0.82 (0.62–1.09) 1.03 (0.76–1.40) 0.4 0.93 (0.83–1.04)
Rectum 1 0.88 (0.55–1.43) 0.97 (0.64–1.48) 0.94 (0.59–1.52) 0.89 0.93 (0.80–1.08)
aReference category/quartile of intake.
bSee for one s.d. of increase based on the intake of the subcohort (Table 1).
cRate ratios adjusted for age and sex.
dRate ratios adjusted for
age, sex, Quetelet Index (QI), smoking, energy intake and family history of colorectal cancer (CRC).
eRate ratios per increment of 15 gday
 1 (s.d. in subcohort), equivalent to one
standard sandwich filling.
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yTable 3 Adjusted RR
a for colon and rectal cancer patients with a K-ras mutation status
b according to the intake of fresh meat, meat products and fish
Quartile/category of intake
Exposure 1
c 234 P for trend
RR (95% CI) for one
s.d. increase in intake
d
Total fresh meat
Cases
K-ras
 /K-ras
+ Colon 68/35 80/29 76/45 66/35
Rectum 25/15 21/24 25/14 18/12
RRK-ras  (95% CI) Colon 1 1.16 (0.82–1.64) 1.05 (0.74–1.49) 0.94 (0.65–1.36) 0.61 0.95 (0.84–1.07)
Rectum 1 0.85 (0.47–1.55) 1.02 (0.58–1.80) 0.76 (0.41–1.44) 0.56 0.93 (0.75–1.15)
RRK-ras+ (95% CI) Colon 1 0.83 (0.50–1.37) 1.25 (0.79–2.00) 1.01 (0.61–1.66) 0.57 0.99 (0.85–1.16)
Rectum 1 1.53 (0.80–2.94) 0.82 (0.39–1.72) 0.68 (0.31–1.47) 0.1 0.85 (0.67–1.07)
Beef
Cases
K-ras
 /K-ras
+ Colon 62/32 66/29 66/39 96/44
Rectum 21/16 25/23 18/12 25/14
RRK-ras  (95% CI) Colon 1 1.04 (0.72–1.49) 1.05 (0.72–1.51) 1.36 (0.96–1.93) 0.08 1.08 (0.97–1.20)
Rectum 1 1.16 (0.64–2.12) 0.89 (0.46–1.71) 1.06 (0.57–1.94) 0.93 1.02 (0.81–1.27)
RRK-ras+ (95% CI) Colon 1 0.87 (0.52–1.47) 1.18 (0.73–1.92) 1.14 (0.71–1.83) 0.38 1.04 (0.89–1.22)
Rectum 1 1.36 (0.70–2.63) 0.74 (0.34–1.61) 0.75 (0.35–1.61) 0.2 0.84 (0.61–1.16)
Pork
Cases
K-ras
 /K-ras
+ Colon 85/33 74/42 68/40 63/29
Rectum 31/12 25/19 18/18 15/16
RRK-ras  (95% CI) Colon 1 0.86 (0.61–1.20) 0.77 (0.55–1.08) 0.72 (0.51–1.02) 0.05 0.91 (0.80–1.05)
Rectum 1 0.81 (0.48–1.39) 0.58 (0.32–1.04) 0.50 (0.26–0.93) 0.01 0.74 (0.57–0.96)
RRK-ras+ (95% CI) Colon 1 1.30 (0.80–2.09) 1.24 (0.76–2.02) 0.90 (0.53–1.53) 0.68 0.97 (0.82–1.15)
Rectum 1 1.52 (0.73–3.17) 1.38 (0.65–2.94) 1.21 (0.56–2.60) 0.75 1.03 (0.82–1.29)
Minced meat
Cases
K-ras
 /K-ras
+ Colon 66/34 79/37 89/36 56/37
Rectum 19/14 17/19 32/20 21/12
RRK-ras  (95% CI) Colon 1 1.16 (0.82–1.64) 1.37 (0.97–1.92) 0.85 (0.58–1.25) 0.68 0.93 (0.82–1.04)
Rectum 1 0.89 (0.46–1.74) 1.77 (0.99–3.19) 1.17 (0.62–2.19) 0.21 1.18 (0.99–1.40)
RRK-ras+ (95% CI) Colon 1 1.04 (0.64–1.68) 1.06 (0.64–1.74) 1.07 (0.65–1.75) 0.78 0.98 (0.83–1.16)
Rectum 1 1.28 (0.64–2.56) 1.36 (0.68–2.72) 0.81 (0.37–1.79) 0.66 0.87 (0.68–1.12)
Liver
Cases
K-ras
 /K-ras
+ Colon 184/98 106/46
Rectum 55/41 34/24
RRK-ras  (95% CI) Colon 1 1.10 (0.86–1.42) 0.44 1.02 (0.91–1.14)
Rectum 1 1.15 (0.74–1.79) 0.54 1.05 (0.89–1.24)
RRK-ras+ (95% CI) Colon 1 0.92 (0.63–1.33) 0.65 1.01 (0.85–1.19)
Rectum 1 1.07 (0.63–1.80) 0.8 0.97 (0.74–1.28)
Chicken
Cases
K-ras
 /K-ras
+ Colon 73/42 73/27 62/35 82/40
Rectum 20/13 24/19 16/17 29/16
RRK-ras  (95% CI) Colon 1 0.96 (0.68–1.36) 0.81 (0.57–1.16) 0.91 (0.65–1.28) 0.44 0.96 (0.84–1.09)
Rectum 1 1.19 (0.64–2.18) 0.76 (0.39–1.49) 1.23 (0.69–2.21) 0.75 1.04 (0.85–1.26)
RRK-ras+ (95% CI) Colon 1 0.64 (0.39–1.06) 0.80 (0.51–1.28) 0.80 (0.51–1.26) 0.52 0.95 (0.79–1.14)
Rectum 1 1.39 (0.68–2.85) 1.20 (0.57–2.53) 0.97 (0.46–2.03) 0.75 0.88 (0.68–1.15)
Other meat
Cases
K-ras
 /K-ras
+ Colon 201/101 89/43
Rectum 57/43 32/22
RRK-ras  (95% CI) Colon 1 1.16 (0.89–1.52) 0.28 1.08 (0.96–1.21)
Rectum 1 0.90 (0.63–2.23) 0.14 0.97 (0.81–1.17)
RRK-ras+ (95% CI) Colon 1 1.16 (0.79–1.70) 0.44 1.07 (0.93–1.23)
Rectum 1 1.24 (0.73–2.10) 0.43 1.04 (0.87–1.24)
Meat products
e
Cases
K-ras
 /K-ras
+ Colon 65/40 59/33 76/41 90/30
Rectum 28/14 20/91 8 /20 23/22
RRK-ras  (95% CI) Colon 1 0.91 (0.63–1.33) 1.10 (0.76–1.57) 1.42 (1.00–2.03) 0.03 1.11 (0.99–1.25)
e
Rectum 1 0.71 (0.39–1.30) 0.62 (0.34–1.16) 0.84 (0.45–1.58) 0.51 0.91 (0.73–1.14)
e
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ymutations exist. However, in this study, no associations were
found between any of the fresh meat variables and risk of colon or
rectal cancer with specific point mutations. This could be due to
the expected low content of carcinogens in prepared fresh meat
consumed in this cohort, and also to the lack of correlation
between meat preparation and the amount of fresh meat
consumed. Surprisingly, associations were observed between beef,
pork and meat products and cancer with a wild-type K-ras gene.
Possibly beef, pork and meat products exert their action through
another pathway than the K-ras signalling route. Although these
associations were weak and the inverse association for high
consumption of pork cannot readily be explained, they are
intriguing and require replication and further study.
It is hypothesised that fat content of meat could influence CRC
risk by increasing the excretion of bile acids (Norat et al, 2002).
The products of the bile acid excretion may act as tumour
promoters by a nonspecific effect that increases cell proliferation
in the mucosa layer (Norat et al, 2002). However, total fat intake
(Brink et al, 2004) as well as total fresh meat consumption was not
associated with overall colon and rectal cancer risk nor with K-ras
mutation status. In the previous study (Brink et al, 2004), only o-6
polyunsaturated fat (PUFA) was observed to be associated with
specific K-ras mutations; however, this type of fat is not
predominantly present in meat.
Nitrosamines and their precursors are compounds observed in
red and processed meat (Mirvish et al, 2002) or can be
endogenously formed (Bingham et al, 2002). Alkylating DNA
agents like nitrosamines could generate O
6-methylguanines and
these have been detected in human colonic tissue (Hall et al, 1991).
N-nitroso compounds could also induce G4A transitions in
codons 12 or 13 of the K-ras gene of rat colon carcinomas (Zarbl
et al, 1985; Topal, 1988; Jacoby et al, 1992) or in human colonic
tissue (Hughes et al, 2001; Bingham et al, 2002). In the current
study, no clear association was observed for daily consumption of
meat products and overall colon and rectal cancer risk. When the
absence or presence of K-ras mutations was taken into account, a
high intake of meat products was found to be positively associated
with colon tumours with a wild-type K-ras gene, as discussed
above. In contrast, subgroup analysis of specific point mutations
in the K-ras gene showed that high consumption of meat products
is positively associated with rectal tumours harbouring a G4A
transition. Although the association was not statistically signifi-
cant, this observation is in line with the biological evidence (Zarbl
et al, 1985; Topal, 1988; Jacoby et al, 1992; Hughes et al, 2001;
Bingham et al, 2002). Why the association in our study is confined
to the rectum and not to the colon remains unclear. A plausible
explanation for differences in tumour site could be due to the
duration of contact with, and the concentration of, the potential
dietary carcinogens like nitrosamines. Possibly, the lower transit
time of stool in the rectum as compared to the colon leads to an
increased exposure time for the rectum. On the other hand, this
could be a chance finding, especially concerning the observation
that no association was observed between meat products and rectal
cancer overall nor with the K-ras mutation status Therefore, more
aetiological insight in the underlying mechanisms is required to
clarify this issue.
We acknowledge that multiple comparisons were performed so
that some of the observed associations are chance findings.
Therefore, caution is warranted in interpreting the results.
In conclusion, our results indicate that total fresh meat and fish
are not associated with colon or rectal cancer risk or with the K-ras
mutation status of these cancer types. However, consumption of
beef, pork and meat products appear to be associated with colon or
rectal tumours with a wild-type K-ras gene, suggesting that they
may exert their actions in colon or rectal cancer through a pathway
independent of a mutation in the K-ras gene.
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Table 3 (Continued)
Quartile/category of intake
Exposure 1
c 234 P for trend
RR (95% CI) for one
s.d. increase in intake
d
RRK-ras+ (95% CI) Colon 1 0.84 (0.52–1.37) 1.00 (0.63–1.59) 0.77 (0.45–1.32) 0.51 0.90 (0.73–1.11)
e
Rectum 1 0.62 (0.26–1.46) 1.26 (0.61–2.61) 1.41 (0.67–2.99) 0.17 1.05 (0.86–1.27)
e
Fish
Cases
K-ras
 /K-ras
+ Colon 84/37 81/36 74/35 51/36
Rectum 25/19 20/11 24/24 20/11
RRK-ras  (95% CI) Colon 1 1.30 (0.93–1.81) 0.80 (0.57–1.12) 0.87 (0.60–1.26) 0.13 0.88 (0.77–1.02)
Rectum 1 0.97 (0.53–1.79) 0.86 (0.48–1.52) 1.06 (0.58–1.94) 0.99 0.97 (0.81–1.17)
RRK-ras+ (95% CI) Colon 1 1.29 (0.79–2.10) 0.87 (0.54–1.42) 1.38 (0.85–2.25) 0.52 1.00 (0.85–1.19)
Rectum 1 0.76 (0.35–1.61) 1.13 (0.61–2.07) 0.78 (0.37–1.65) 0.84 0.86 (0.69–1.07)
aMultivariate adjusted rate ratios (RRs) for age, sex, Quetelet Index (QI), smoking, energy intake and family history of CRC and their 95% confidence intervals.
bWild-type K-ras (K-
ras
 ): no mutation in the exon 1 fragment of the gene, mutated K-ras (K-ras
+): at least one mutation in the exon 1 fragment of the gene.
cReference category/quartile of intake.
dSee for one s.d. of increase based on the intake of the subcohort (Table 1).
eRate ratios per increment of 15 gday
 1 (s.d. in subcohort), equivalent to one standard sandwich filling.
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yTable 4 Adjusted RR
a for colon and rectal cancer patients with specific point mutations
b in the K-ras oncogene according to the intake of fresh meat,
meat products and fish
Quartile/category of intake
Exposure 1
c 234
P for
trend
RR (95% CI) for one s.d.
increase in intake
d
Total fresh meat
Cases
G4A
+/G4T
+,G 4C
+
Colon 16/16 16/12 31/13 19/15
Rectum 11/5 13/12 7/63 /8
RRG4Aþ (95% CI) Colon 1 0.98 (0.48–1.98) 1.81 (0.97–3.40) 1.11 (0.55–2.22) 0.34 1.02 (0.85–1.22)
Rectum 1 1.11 (0.49–2.51) 0.62 (0.24–1.64) 0.28 (0.08–1.03) 0.02 0.71 (0.55–0.93)
RRG4Tþ;G4Cþ (95% CI) Colon 1 0.75 (0.35–1.61) 0.83 (0.40–1.73) 1.00 (0.48–2.08) 0.97 1.01 (0.78–1.32)
Rectum 1 2.44 (0.86–6.92) 1.01 (0.31–3.27) 1.19 (0.38–3.68) 0.62 0.94 (0.65–1.36)
Beef
Cases
G4A
+/G4T
+,G 4C
+
Colon 16/14 19/71 9 /18 28/17
Rectum 7/9 14/87 /65 /9
RRG4Aþ (95% CI) Colon 1 1.13 (0.57–2.26) 1.13 (0.57–2.21) 1.41 (0.74–2.66) 0.3 1.11 (0.91–1.36)
Rectum 1 2.00 (0.79–5.06) 1.08 (0.37–3.11) 0.68 (0.21–2.26) 0.25 0.67 (0.47–0.95)
RRG4Tþ;G4Cþ (95% CI) Colon 1 0.48 (0.19–1.19) 1.26 (0.62–2.58) 1.02 (0.50–2.08) 0.47 0.99 (0.78–1.26)
Rectum 1 0.81 (0.31–2.17) 0.63 (0.21–1.87) 0.82 (0.30–2.21) 0.64 1.06 (0.69–1.61)
Pork
Cases
G4A
+/G4T
+,G 4C
+
Colon 19/13 23/18 25/12 15/13
Rectum 6/6 10/11 10/77 /8
RRG4Aþ (95% CI) Colon 1 1.23 (0.65–2.30) 1.28 (0.69–2.40) 0.77 (0.38–1.56) 0.53 0.86 (0.70–1.06)
Rectum 1 1.67 (0.60–4.66) 1.71 (0.60–4.90) 1.23 (0.40–3.77) 0.72 0.92 (0.68–1.25)
RRG4Tþ;G4Cþ (95% CI) Colon 1 1.43 (0.68–2.98) 0.98 (0.43–2.22) 1.07 (0.48–2.41) 0.88 1.10 (0.83–1.46)
Rectum 1 1.72 (0.63–4.71) 0.99 (0.33–2.97) 1.07 (0.37–3.13) 0.74 1.06 (0.74–1.51)
Minced meat
Cases
G4A
+/G4T
+,G 4C
+
Colon 20/12 15/18 19/16 28/10
Rectum 7/7 11/89 /11 6/6
RRG4Aþ (95% CI) Colon 1 0.71 (0.36–1.40) 0.94 (0.49–1.81) 1.34 (0.73–2.46) 0.24 1.09 (0.91–1.31)
Rectum 1 1.56 (0.61–4.01) 1.27 (0.47–3.47) 0.90 (0.30–2.72) 0.75 0.86 (0.61–1.22)
RRG4Tþ;G4Cþ (95% CI) Colon 1 1.44 (0.69–3.04) 1.36 (0.62–2.95) 0.83 (0.36–1.95) 0.64 0.89 (0.67–1.18)
Rectum 1 1.06 (0.39–2.89) 1.51 (0.59–3.88) 0.77 (0.25–2.38) 0.85 0.88 (0.61–1.27)
Liver
Cases
G4A
+/G4T
+,G 4C
+
Colon 56/36 26/20
Rectum 23/18 10/14
RRG4Aþ (95% CI) Colon 1 0.91 (0.55–1.49) 0.7 1.01 (0.82–1.26)
Rectum 1 0.79 (0.38–1.65) 0.53 0.53 (0.31–0.91)
RRG4Tþ;G4Cþ (95% CI) Colon 1 1.12 (0.64–1.94) 0.7 1.10 (0.90–1.36)
Rectum 1 1.45 (0.69–3.05) 0.32 1.18 (0.92–1.50)
Chicken
Cases
G4A
+/G4T
+,G 4C
+
Colon 24/17 14/10 21/13 23/16
Rectum 7/6 11/10 8/97 /7
RRG4Aþ (95% CI) Colon 1 0.57 (0.29–1.13) 0.84 (0.46–1.53) 0.78 (0.43–1.42) 0.66 0.94 (0.74–1.18)
Rectum 1 1.59 (0.61–4.19) 1.08 (0.38–3.07) 0.85 (0.29–2.46) 0.52 0.88 (0.59–1.32)
RRG4Tþ;G4Cþ (95% CI) Colon 1 0.59 (0.27–1.29) 0.74 (0.36-.53) 0.81 (0.41–1.61) 0.7 0.95 (0.69–1.30)
Rectum 1 1.52 (0.55–4.19) 1.36 (0.47–3.91) 0.86 (0.29–2.59) 0.65 0.80 (0.54–1.18)
Other meat
Cases
G4A
+/G4T
+,G 4C
+
Colon 55/42 27/14
Rectum 20/22 13/10
RRG4Aþ (95% CI) Colon 1 1.33 (0.82–2.17) 0.25 1.12 (0.97–1.31)
Rectum 1 1.57 (0.79–3.13) 0.2 1.15 (0.95–1.39)
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